“…HPSE inhibitors, including heparin and its analogs, sulfated oligosaccharides and their analogs, Abs, natural drugs, and RNA interference, have been used in research and clinical treatment of malignancies, 13 and the sulfated oligosaccharide PI-88 is under the clinical phase III experiment. 14,15 PG545, an HS-mimetic HSPE inhibitor, elicits lymphoma cell apoptosis. 16 Although these HPSE inhibitors have significant anticancer activities, they still have some disadvantages, such as heparin affects the coagulation system, sulfated oligosaccharides inhibit HPSE extensively, and HPSE Abs are too expensive.…”